- 专利标题： DUAL MODE 18F-LABELLED THERANOSTIC COMPOUNDS AND USES THEREOF
-
申请号： US17415649申请日： 2019-12-18
-
公开(公告)号： US20220062446A1公开(公告)日： 2022-03-03
- 发明人: David Perrin , Aron Roxin , Mathieu Lepage , Sungjoon Huh , Zhibo Liu , Rajaguru Kandasamy , Francois Benard , Kuo-Shyan Lin , Hsiou-Ting Kuo , Chengcheng Zhang
- 申请人： Provincial Health Services Authority , The University of British Columbia
- 申请人地址： CA Vancouver; CA Vancouver
- 专利权人： Provincial Health Services Authority,The University of British Columbia
- 当前专利权人： Provincial Health Services Authority,The University of British Columbia
- 当前专利权人地址： CA Vancouver; CA Vancouver
- 国际申请： PCT/CA2019/051853 WO 20191218
- 主分类号： A61K51/04
- IPC分类号： A61K51/04 ; A61K51/08 ; C07F5/02
摘要：
A compound or molecular complex. The compound or molecular complex comprises: a metal chelator configured for chelation with a radioactive isotope or a non-radioactive isotope; and a trifluoroborate (BF3)-containing moiety configured for 19F/18F exchange or a precursor thereof; and optionally a cell-targeting domain.
信息查询
